StockMacro
Menu

Solid Biosciences

$6.25 -9.2% in 6 monthsMarket cap $697.6M

SLDB on XNAS, Health Care, Solid Biosciences Inc., job postings

Measures activity, not value. Not investment advice.

Short interest of 17.1M shares is 1.7 times a year earlier while stock is up 40% in 12 months.

  • BadFree cash flow was negative $200.3M over 12 months

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

Solid Biosciences Inc is a life sciences company focused on advancing a portfolio of current and future gene therapy candidates, including SGT-003 for the treatment of Duchenne muscular dystrophy, SGT-212 for the treatment of Friedreich's ataxia, SGT-501 for the treatment of catecholaminergic polymorphic ventricular tachycardia, SGT-601 for the treatment of TNNT2-mediated dilated cardiomyopathy, and additional assets for the treatment of genetic cardiac and neuromuscular diseases. The majority of its current programs are designed to treat these diseases with gene transfer products. The company operates in a single segment, developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases.

Industry
Biological products, (no diagnostic substances) (Health Care)
Employees
121
Website
solidbio.com
Listed
Nasdaq, US
Last results
6 Mar 2026
Next results
no estimate
Revenue and net income per quarter. Quarter to 30 Sep 2026: net loss $53.9M.
Quarter to 31 Dec 2021: revenue –, net income -$18.6MQuarter to 31 Mar 2022: revenue –, net income -$25.3MQuarter to 30 Jun 2022: revenue –, net income -$25.1MQuarter to 30 Sep 2022: revenue –, net income -$20.4MQuarter to 31 Dec 2022: revenue –, net income -$15.2MQuarter to 31 Mar 2023: revenue –, net income -$30.1MQuarter to 30 Jun 2023: revenue –, net income -$24.6MQuarter to 30 Sep 2023: revenue –, net income -$21.0MQuarter to 31 Dec 2023: revenue –, net income -$20.3MQuarter to 31 Mar 2024: revenue –, net income -$24.3MQuarter to 30 Jun 2024: revenue –, net income -$25.1MQuarter to 30 Sep 2024: revenue –, net income -$32.7MQuarter to 31 Dec 2024: revenue –, net income -$42.6MQuarter to 31 Mar 2025: revenue –, net income -$39.3MQuarter to 30 Jun 2025: revenue –, net income -$39.5MQuarter to 30 Sep 2025: revenue –, net income -$45.8MQuarter to 31 Dec 2025: revenue –, net income -$49.8MQuarter to 31 Mar 2026: revenue –, net income -$56.7MQuarter to 30 Jun 2026: revenue –, net income -$54.8MQuarter to 30 Sep 2026: revenue –, net income -$53.9M
31 Dec 2021RevenueNet incomeNet losstallest bar $56.7M30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026–-$53.9M
30 Jun 2026–-$54.8M
31 Mar 2026–-$56.7M
31 Dec 2025–-$49.8M
30 Sep 2025–-$45.8M
30 Jun 2025–-$39.5M
31 Mar 2025–-$39.3M
31 Dec 2024–-$42.6M
30 Sep 2024–-$32.7M
30 Jun 2024–-$25.1M
31 Mar 2024–-$24.3M
31 Dec 2023–-$20.3M
30 Sep 2023–-$21.0M
30 Jun 2023–-$24.6M
31 Mar 2023–-$30.1M
31 Dec 2022–-$15.2M
30 Sep 2022–-$20.4M
30 Jun 2022–-$25.1M
31 Mar 2022–-$25.3M
31 Dec 2021–-$18.6M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. – –
Revenue growthRevenue of the last 12 months compared with the 12 months before. – +8.2%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. -$215.3M -$167.1M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). -$1.79 -$2.51
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. – – 70.4%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. – – -98.6%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. – – -47.8%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. -76.9% -58.2%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. -$200.3M -$133.2M
CashCash, cash equivalents and short-term investments on the latest balance sheet. $348.9M $236.1M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. – –
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). – –
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. – 0.0
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $3.07
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. loss 21.6
P/SPrice to sales: market cap divided by revenue of the last 12 months. – 8.0
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. – 6.0
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 2.0 2.0

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
Solid BiosciencesSLDB (this company) $697.6Mloss–––
Attovia TherapeuticsATTO $690.3M––––
Aura BiosciencesAURA $715.0Mloss–––
Monte Rosa TherapeuticsGLUE $738.3Mloss10.5-61%-186%
MeiraGTxMGTX $779.9M10.01.9+1366%19.5%
Iambic TherapeuticsIAM $621.4M––––

Insider Buy/Sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

-$25K

bought $0, sold $25K

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

-0.6%

156 13F filers vs 157

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

over 100%

118.8M shares held by 13F filers (30 Sep 2026) of 111.6M outstanding (30 Oct 2026); above 100%: the share count is probably stale

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

12%

13.3M shares sold short (30 Oct 2026) of 111.6M outstanding (30 Oct 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

10.7

13.3M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

+8.2%

12.3M shares sold short in the report before, 13.3M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

71%

71% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 52%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

–

We do not track this company's careers site yet.

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

We do not track this company's careers site yet.

Employees Total staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.

–

No headcount in its annual reports in our data.

Visa hiring (foreign workers) Applications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.

–

No data for this company

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

–

No data for this company

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

–

No data for this company

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

–

No data for this company

Lobbying What the company reported spending on federal lobbying over the last four quarters.

–

No data for this company

Layoff notices Workers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).

–

No data for this company

News (7d) Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

14

14 articles in the last 7 days; its usual week has 1 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

14×

14 articles in the last 7 days; its usual week has 1.

Unusual now sharp changes in the last 90 days, compared with its own past

  • Short interest 17.1M, 1.7× a year earlier

Price $6.25 on 20 Nov 2026, +40% over 12 months (12-month range $4.46 to $11.15)

  • Sharp change
  • 8-K and other filings
Insider net buying (open market). Insiders sold a net $2.7M in the last 12 months (the 12 months before: $25.8M).
H-1B/E-3 applications certified. H-1B/E-3 applications certified: 4 published in the last 12 months, +33% on the 12 months before.
Capital spending per quarter. Capital spending $498K in the latest quarter, +486% on a year earlier.
Institutional holders (13F filers). 156 13F filers reported holding it in the latest 13F quarter, +25% on a year earlier.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: revenue per quarter, federal obligations, lobbying spend, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
29 Sep 2026Sharp changeShort interest spike: short interest spike, 17.1M vs usual 9.8M (2026-09-15); 1.7x the same period a year earlier
15 Sep 2026Sharp changeShort interest spike: short interest spike, 16.4M vs usual 9.8M (2026-08-31); 1.7x the same period a year earlier
1 Sep 2026Sharp changeShort interest spike: short interest spike, 16.6M vs usual 9.8M (2026-08-14); 1.7x the same period a year earlier
18 Aug 2026Sharp changeShort interest spike: short interest spike, 17.0M vs usual 9.8M (2026-07-31); 1.7x the same period a year earlier
10 Apr 20268-K and other filingsDirector or officer change
10 Apr 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
2 Sep 2025Sharp changeShort interest spike: short interest spike, 9.8M vs usual 2.8M (2025-08-15); 5.7x the same period a year earlier
12 Aug 2025Sharp changeShort interest spike: short interest spike, 10.1M vs usual 2.5M (2025-07-31); 6.3x the same period a year earlier
29 Jul 2025Sharp changeShort interest spike: short interest spike, 10.2M vs usual 2.2M (2025-07-15); 6.2x the same period a year earlier
1 Jul 2025Sharp changeShort interest spike: short interest spike, 8.1M vs usual 1.9M (2025-06-13); 8.9x the same period a year earlier
17 Jun 2025Sharp changeShort interest spike: short interest spike, 8.3M vs usual 1.8M (2025-05-30); 9.9x the same period a year earlier
13 Jun 20258-K and other filingsDirector or officer change
13 Jun 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
3 Jun 2025Sharp changeShort interest spike: short interest spike, 9.1M vs usual 1.7M (2025-05-15); 9.7x the same period a year earlier
15 May 2025Sharp changeMany funds opening a new position: many funds opening a new position, 51 vs usual 9 (2025-03-31); 2.4x the same period a year earlier
13 May 2025Sharp changeShort interest spike: short interest spike, 7.1M vs usual 1.7M (2025-04-30); 7.8x the same period a year earlier
29 Apr 2025Sharp changeShort interest spike: short interest spike, 8.1M vs usual 1.7M (2025-04-15); 7.7x the same period a year earlier
15 Apr 2025Sharp changeShort interest spike: short interest spike, 8.6M vs usual 1.7M (2025-03-31); 9.4x the same period a year earlier
1 Apr 2025Sharp changeShort interest spike: short interest spike, 7.8M vs usual 1.7M (2025-03-14); 12.8x the same period a year earlier
18 Mar 2025Sharp changeShort interest spike: short interest spike, 7.3M vs usual 1.6M (2025-02-28); 11.6x the same period a year earlier
22 Feb 2025Sharp changeClustered insider buying: clustered insider buying (3 independent filers, 3 filing(s) in 30 days, value_usd total 26.1M)
19 Nov 2024Sharp changeMany funds opening a new position: many funds opening a new position, 23 vs usual 6.50 (2024-09-30); 7.7x the same period a year earlier
20 Aug 2024Sharp changeMany funds opening a new position: many funds opening a new position, 27 vs usual 6.50 (2024-06-30); 13.5x the same period a year earlier
16 Jul 2024Sharp changeShort interest spike: short interest spike, 3.0M vs usual 233K (2024-06-28); 69.7x the same period a year earlier
18 Jun 2024Sharp changeShort interest spike: short interest spike, 840K vs usual 124K (2024-05-31); 32.9x the same period a year earlier
11 Jun 20248-K and other filingsDirector or officer change
11 Jun 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
28 May 2024Sharp changeShort interest spike: short interest spike, 929K vs usual 43K (2024-05-15); 22.8x the same period a year earlier
21 May 2024Sharp changeMany funds opening a new position: many funds opening a new position, 21 vs usual 6.50 (2024-03-31); 3.0x the same period a year earlier
14 May 2024Sharp changeShort interest spike: short interest spike, 914K vs usual 43K (2024-04-30); 23.7x the same period a year earlier
30 Apr 2024Sharp changeShort interest spike: short interest spike, 1.0M vs usual 43K (2024-04-15); 23.3x the same period a year earlier
16 Apr 2024Sharp changeShort interest spike: short interest spike, 921K vs usual 42K (2024-03-28); 25.5x the same period a year earlier
2 Apr 2024Sharp changeShort interest spike: short interest spike, 615K vs usual 41K (2024-03-15); 29.3x the same period a year earlier
12 Mar 2024Sharp changeShort interest spike: short interest spike, 634K vs usual 40K (2024-02-29); 49.1x the same period a year earlier
5 Mar 2024Sharp changeShort interest spike: short interest spike, 607K vs usual 38K (2024-02-15); 44.0x the same period a year earlier
9 Jun 20238-K and other filingsDirector or officer change
22 May 20238-K and other filingsDirector or officer change
22 May 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
9 Jan 20238-K and other filingsDirector or officer change
9 Dec 20228-K and other filingsPrivate placement of securities (Form D)
5 Dec 20228-K and other filingsDirector or officer change
5 Dec 20228-K and other filingsRestructuring costs announced
5 Dec 20228-K and other filingsCompleted an acquisition or asset sale
1 Dec 20228-K and other filingsDirector or officer change
30 Sep 20228-K and other filingsDirector or officer change
30 Sep 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
6 Jun 20228-K and other filingsDelisting notice or listing transfer
27 Apr 20228-K and other filingsDirector or officer change
27 Apr 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
Insider net buying (open market)
Month from 1 Mar 2022: -$59K published
Month from 1 Feb 2023: -$15K published
Month from 1 Jun 2023: -$2K published
Month from 1 Dec 2023: -$83K published
Month from 1 Jan 2024: $23.8M published
Month from 1 May 2024: -$5K published
Month from 1 Jun 2024: $8K published
Month from 1 Oct 2024: -$19K published
Month from 1 Dec 2024: -$132K published
Month from 1 Jan 2025: -$21K published
Month from 1 Feb 2025: $26.0M published
Month from 1 Mar 2025: $10K published
Month from 1 Oct 2025: -$17K published
Month from 1 Nov 2025: -$14K published
Month from 1 Dec 2025: -$117K published
Month from 1 Jan 2026: -$37K published
Month from 1 Feb 2026: -$2.5M published
Month from 1 Oct 2026: -$25K published
H-1B/E-3 applications certified
Quarter from 1 Jul 2022: 6 published
Quarter from 1 Jul 2023: 2 published
Quarter from 1 Jul 2024: 2 published
Quarter from 1 Jul 2025: 3 published
Quarter from 1 Jan 2026: 2 published
Quarter from 1 Jul 2026: 1 published
Quarter from 1 Oct 2026: 1 published
Capital spending per quarter
Quarter ended 31 Dec 2021: $660K, +1000% on a year earlier; public on 15 Mar 2022
Quarter ended 31 Mar 2022: $184K, +426% on a year earlier; public on 28 Apr 2022
Quarter ended 30 Jun 2022: $1.1M, +226% on a year earlier; public on 12 Aug 2022
Quarter ended 30 Sep 2022: $839K, +254% on a year earlier; public on 11 Nov 2022
Quarter ended 31 Dec 2022: $856K, +30% on a year earlier; public on 24 Mar 2023
Quarter ended 31 Mar 2023: $506K, +175% on a year earlier; public on 12 May 2023
Quarter ended 30 Jun 2023: $536K, -53% on a year earlier; public on 15 Aug 2023
Quarter ended 30 Sep 2023: $383K, -54% on a year earlier; public on 9 Nov 2023
Quarter ended 31 Dec 2023: $90K, -89% on a year earlier; public on 14 Mar 2024
Quarter ended 31 Mar 2024: $149K, -71% on a year earlier; public on 16 May 2024
Quarter ended 30 Jun 2024: $286K, -47% on a year earlier; public on 14 Aug 2024
Quarter ended 30 Sep 2024: $15K, -96% on a year earlier; public on 7 Nov 2024
Quarter ended 31 Dec 2024: $204K, +127% on a year earlier; public on 7 Mar 2025
Quarter ended 31 Mar 2025: $126K, -15% on a year earlier; public on 16 May 2025
Quarter ended 30 Jun 2025: $377K, +32% on a year earlier; public on 13 Aug 2025
Quarter ended 30 Sep 2025: $85K, +467% on a year earlier; public on 4 Nov 2025
Quarter ended 31 Dec 2025: $565K, +177% on a year earlier; public on 20 Mar 2026
Quarter ended 31 Mar 2026: $165K, +31% on a year earlier; public on 13 May 2026
Quarter ended 30 Jun 2026: $150K, -60% on a year earlier; public on 7 Aug 2026
Quarter ended 30 Sep 2026: $498K, +486% on a year earlier; public on 5 Nov 2026
Institutional holders (13F filers)
31 Dec 2021 report: 78; public on 14 Feb 2022
31 Mar 2022 report: 74; public on 16 May 2022
30 Jun 2022 report: 65; public on 15 Aug 2022
30 Sep 2022 report: 56; public on 14 Nov 2022
31 Dec 2022 report: 36; public on 14 Feb 2023
31 Mar 2023 report: 37; public on 15 May 2023
30 Jun 2023 report: 34; public on 14 Aug 2023
30 Sep 2023 report: 35; public on 14 Nov 2023
31 Dec 2023 report: 37; public on 14 Feb 2024
31 Mar 2024 report: 53; public on 15 May 2024
30 Jun 2024 report: 75; public on 14 Aug 2024
30 Sep 2024 report: 90; public on 14 Nov 2024
31 Dec 2024 report: 89; public on 14 Feb 2025
31 Mar 2025 report: 125; public on 15 May 2025
30 Jun 2025 report: 112; public on 14 Aug 2025
30 Sep 2025 report: 125; public on 14 Nov 2025
31 Dec 2025 report: 128; public on 17 Feb 2026
31 Mar 2026 report: 145; public on 15 May 2026
30 Jun 2026 report: 157; public on 14 Aug 2026
30 Sep 2026 report: 156; public on 16 Nov 2026

What is unusual now

  • Made public in the last 90 days: it had 17.1M shares sold short in the 15 Sep 2026 report, 1.7× the same report last year; it also had 16.6M shares sold short in the 14 Aug 2026 report, 1.7× the same report last year. 3 sharp changes in all.
  • Short interest spike: had 17.0M shares sold short in the 31 Jul 2026 report, 1.7× the same report last year Public on 12 Aug 2026.
  • Insider net buying (open market): Insiders sold a net $2.7M in the last 12 months (the 12 months before: $25.8M).
  • H-1B/E-3 applications certified: H-1B/E-3 applications certified: 4 published in the last 12 months, +33% on the 12 months before.

Latest records

The names and amounts behind the totals, newest first

Last 90 days: 1 sale, $25K; no purchases. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
20 Oct 2026Gabriel BrooksChief Medical OfficerSellplanned in advance (10b5-1); after exercising options4,374$5.62$25KForm 4
18 Feb 2026Kevin TanCFO & TreasurerSellplanned in advance (10b5-1); after exercising options5,404$5.82$31KForm 4
18 Feb 2026Gabriel BrooksChief Medical OfficerSellplanned in advance (10b5-1); after exercising options0Not filedNot filedForm 4
18 Feb 2026Jessie HanrahanChief Regulatory OfficerSellplanned in advance (10b5-1); after exercising options4,134$5.82$24KForm 4
18 Feb 2026David T HowtonChief Operating OfficerSellplanned in advance (10b5-1); after exercising options7,469$5.82$43KForm 4
18 Feb 2026Paul HerzichChief Technology OfficerSellplanned in advance (10b5-1); after exercising options3,616$5.82$21KForm 4
18 Feb 2026Ilan GanotDirectorSellplanned in advance (10b5-1); after exercising options2,658$5.82$15KForm 4
18 Feb 2026Alexander CumboPresident and CEOSellplanned in advance (10b5-1); after exercising options16,644$5.82$97KForm 4

156 institutions reported shares at the end of Q3 2026, 100% of the shares outstanding; 22 opened a position, 22 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
Ra Capital Management, L.P.12.0M10.8%$87.0MNo change
Perceptive Advisors LLC11.9M10.7%$86.1MNo change
Bain Capital Life Sciences Investors, LLC9.8M8.79%$70.9MNo change
Siren, L.L.C.7.7M6.89%$55.6MNo change
FMR LLC (Fidelity)7.3M6.52%$52.6M+397K+5.8%
BlackRock, Inc.6.8M6.12%$49.4M-99K-1.4%
RTW Investments, LP5.9M5.29%$42.7M+2.0M+52%
Armistice Capital, LLC4.5M4.03%$32.5M+218K+5.1%
Franklin Templeton Inc4.2M3.76%$27.3M+753K+22%
Vanguard Capital Management LLC4.0M3.56%$28.7M-42K-1.0%

Company events

All 40 company events

In 12 months: 1 major agreement, 1 director or officer change. Results releases and routine reports are left out.

FiledWhat happenedSource
10 Apr 2026Director or officer change8-K
6 Mar 2026Signed a major agreementSame filing: sold shares privately8-K
13 Jun 2025Director or officer changeSame filing: shareholder vote results8-K
18 Feb 2025Signed a major agreement8-K
11 Jun 2024Director or officer changeSame filing: shareholder vote results8-K
8 Jan 2024Signed a major agreementSame filing: sold shares privately8-K
9 Jun 2023Director or officer changeSame filing: shareholder vote results8-K
22 May 2023Director or officer change8-K

The 5 newest of 117 articles that name the company.

Timeline

Several things at once

Two or more unrelated kinds of records unusual within 30 days

18 Mar 2025confirmed

Confirmed across sources Insiders and Institutional holdings and Short interest and volume

Solid Biosciences (SLDB): had 3 insiders buy $26.1M of its shares on the open market within 30 days (3 filings); it also saw 51 13F filers open a new position in the quarter ended 31 Mar 2025, 2.4× the same quarter last year; and it had 10.2M shares sold short in the 15 Jul 2025 report, 6.2× the same report last year. Three unrelated kinds of activity within 192 days.

  • Insiders: Clustered insider buying, became public on 22 Feb 2025
  • Short interest and volume: Short interest spike, became public on 12 Mar 2025
  • Short interest and volume: Short interest spike, became public on 26 Mar 2025
  • Short interest and volume: Short interest spike, became public on 10 Apr 2025
  • Short interest and volume: Short interest spike, became public on 26 Apr 2025
  • Short interest and volume: Short interest spike, became public on 10 May 2025
  • Institutional holdings: Many funds opening a new position, became public on 15 May 2025
  • Short interest and volume: Short interest spike, became public on 28 May 2025
  • Short interest and volume: Short interest spike, became public on 11 Jun 2025
  • Short interest and volume: Short interest spike, became public on 26 Jun 2025
  • Short interest and volume: Short interest spike, became public on 25 Jul 2025
  • Short interest and volume: Short interest spike, became public on 12 Aug 2025
  • Short interest and volume: Short interest spike, became public on 27 Aug 2025
2023-03-31: 72023-06-30: 22023-09-30: 32023-12-31: 42024-03-31: 212024-06-30: 272024-09-30: 232024-12-31: 112025-03-31: 51
The quarter ended 31 Mar 2025 against the 8 quarters before it. this quarterearliernormal: 9
See the evidence (13 changes)

Insiders: Clustered insider buying became public on 22 Feb 2025

Solid Biosciences had 3 insiders buy $26.1M of its shares on the open market within 30 days (3 filings).

Independent buyers
3
Purchase filings (Form 4, code P)
3
Total bought
$26.1M
Window
23 Jan 2025 to 22 Feb 2025

Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

Short interest and volume: Short interest spike became public on 12 Mar 2025

Solid Biosciences had 7.3M shares sold short in the 28 Feb 2025 report, 12× the same report last year.

This period
7.3M (the 28 Feb 2025 report)
Normal report (median of 24 earlier)
1.6M
Typical spread (median absolute deviation)
505K
How far from its usual level
+7.6
Same report last year
634K
History used
2,585 days
2024-02-29: 634K2024-03-15: 615K2024-03-28: 921K2024-04-15: 1.0M2024-04-30: 914K2024-05-15: 929K2024-05-31: 840K2024-06-14: 904K2024-06-28: 3.0M2024-07-15: 1.7M2024-07-31: 1.6M2024-08-15: 1.7M2024-08-30: 1.7M2024-09-13: 1.7M2024-09-30: 1.7M2024-10-15: 1.8M2024-10-31: 1.5M2024-11-15: 1.5M2024-11-29: 1.5M2024-12-13: 1.8M2024-12-31: 2.1M2025-01-15: 2.3M2025-01-31: 2.7M2025-02-14: 2.9M2025-02-28: 7.3M
the 28 Feb 2025 report24 earlier reportsnormal: 1.6M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 26 Mar 2025

Solid Biosciences had 7.8M shares sold short in the 14 Mar 2025 report, 13× the same report last year.

This period
7.8M (the 14 Mar 2025 report)
Normal report (median of 24 earlier)
1.7M
Typical spread (median absolute deviation)
505K
How far from its usual level
+8.3
Same report last year
615K
History used
2,599 days
2024-03-15: 615K2024-03-28: 921K2024-04-15: 1.0M2024-04-30: 914K2024-05-15: 929K2024-05-31: 840K2024-06-14: 904K2024-06-28: 3.0M2024-07-15: 1.7M2024-07-31: 1.6M2024-08-15: 1.7M2024-08-30: 1.7M2024-09-13: 1.7M2024-09-30: 1.7M2024-10-15: 1.8M2024-10-31: 1.5M2024-11-15: 1.5M2024-11-29: 1.5M2024-12-13: 1.8M2024-12-31: 2.1M2025-01-15: 2.3M2025-01-31: 2.7M2025-02-14: 2.9M2025-02-28: 7.3M2025-03-14: 7.8M
the 14 Mar 2025 report24 earlier reportsnormal: 1.7M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 10 Apr 2025

Solid Biosciences had 8.6M shares sold short in the 31 Mar 2025 report, 9.4× the same report last year.

This period
8.6M (the 31 Mar 2025 report)
Normal report (median of 24 earlier)
1.7M
Typical spread (median absolute deviation)
505K
How far from its usual level
+9.3
Same report last year
921K
History used
2,616 days
2024-03-28: 921K2024-04-15: 1.0M2024-04-30: 914K2024-05-15: 929K2024-05-31: 840K2024-06-14: 904K2024-06-28: 3.0M2024-07-15: 1.7M2024-07-31: 1.6M2024-08-15: 1.7M2024-08-30: 1.7M2024-09-13: 1.7M2024-09-30: 1.7M2024-10-15: 1.8M2024-10-31: 1.5M2024-11-15: 1.5M2024-11-29: 1.5M2024-12-13: 1.8M2024-12-31: 2.1M2025-01-15: 2.3M2025-01-31: 2.7M2025-02-14: 2.9M2025-02-28: 7.3M2025-03-14: 7.8M2025-03-31: 8.6M
the 31 Mar 2025 report24 earlier reportsnormal: 1.7M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 26 Apr 2025

Solid Biosciences had 8.1M shares sold short in the 15 Apr 2025 report, 7.7× the same report last year.

This period
8.1M (the 15 Apr 2025 report)
Normal report (median of 24 earlier)
1.7M
Typical spread (median absolute deviation)
488K
How far from its usual level
+8.8
Same report last year
1.0M
History used
2,631 days
2024-04-15: 1.0M2024-04-30: 914K2024-05-15: 929K2024-05-31: 840K2024-06-14: 904K2024-06-28: 3.0M2024-07-15: 1.7M2024-07-31: 1.6M2024-08-15: 1.7M2024-08-30: 1.7M2024-09-13: 1.7M2024-09-30: 1.7M2024-10-15: 1.8M2024-10-31: 1.5M2024-11-15: 1.5M2024-11-29: 1.5M2024-12-13: 1.8M2024-12-31: 2.1M2025-01-15: 2.3M2025-01-31: 2.7M2025-02-14: 2.9M2025-02-28: 7.3M2025-03-14: 7.8M2025-03-31: 8.6M2025-04-15: 8.1M
the 15 Apr 2025 report24 earlier reportsnormal: 1.7M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 10 May 2025

Solid Biosciences had 7.1M shares sold short in the 30 Apr 2025 report, 7.8× the same report last year.

This period
7.1M (the 30 Apr 2025 report)
Normal report (median of 24 earlier)
1.7M
Typical spread (median absolute deviation)
468K
How far from its usual level
+7.7
Same report last year
914K
History used
2,646 days
2024-04-30: 914K2024-05-15: 929K2024-05-31: 840K2024-06-14: 904K2024-06-28: 3.0M2024-07-15: 1.7M2024-07-31: 1.6M2024-08-15: 1.7M2024-08-30: 1.7M2024-09-13: 1.7M2024-09-30: 1.7M2024-10-15: 1.8M2024-10-31: 1.5M2024-11-15: 1.5M2024-11-29: 1.5M2024-12-13: 1.8M2024-12-31: 2.1M2025-01-15: 2.3M2025-01-31: 2.7M2025-02-14: 2.9M2025-02-28: 7.3M2025-03-14: 7.8M2025-03-31: 8.6M2025-04-15: 8.1M2025-04-30: 7.1M
the 30 Apr 2025 report24 earlier reportsnormal: 1.7M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Institutional holdings: Many funds opening a new position became public on 15 May 2025

Solid Biosciences saw 51 13F filers open a new position in the quarter ended 31 Mar 2025, 2.4× the same quarter last year.

This period
51 (the quarter ended 31 Mar 2025)
Normal quarter (median of 8 earlier)
9
Typical spread (median absolute deviation)
6.5
How far from its usual level
+4.4
Same quarter last year
21
History used
2,557 days
2023-03-31: 72023-06-30: 22023-09-30: 32023-12-31: 42024-03-31: 212024-06-30: 272024-09-30: 232024-12-31: 112025-03-31: 51
the quarter ended 31 Mar 20258 earlier quartersnormal: 9

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

Check it at the source: SEC Form 13F data sets.

Short interest and volume: Short interest spike became public on 28 May 2025

Solid Biosciences had 9.1M shares sold short in the 15 May 2025 report, 9.7× the same report last year.

This period
9.1M (the 15 May 2025 report)
Normal report (median of 24 earlier)
1.7M
Typical spread (median absolute deviation)
453K
How far from its usual level
+10.9
Same report last year
929K
History used
2,661 days
2024-05-15: 929K2024-05-31: 840K2024-06-14: 904K2024-06-28: 3.0M2024-07-15: 1.7M2024-07-31: 1.6M2024-08-15: 1.7M2024-08-30: 1.7M2024-09-13: 1.7M2024-09-30: 1.7M2024-10-15: 1.8M2024-10-31: 1.5M2024-11-15: 1.5M2024-11-29: 1.5M2024-12-13: 1.8M2024-12-31: 2.1M2025-01-15: 2.3M2025-01-31: 2.7M2025-02-14: 2.9M2025-02-28: 7.3M2025-03-14: 7.8M2025-03-31: 8.6M2025-04-15: 8.1M2025-04-30: 7.1M2025-05-15: 9.1M
the 15 May 2025 report24 earlier reportsnormal: 1.7M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 11 Jun 2025

Solid Biosciences had 8.3M shares sold short in the 30 May 2025 report, 9.9× the same report last year.

This period
8.3M (the 30 May 2025 report)
Normal report (median of 24 earlier)
1.8M
Typical spread (median absolute deviation)
432K
How far from its usual level
+10.3
Same report last year
840K
History used
2,676 days
2024-05-31: 840K2024-06-14: 904K2024-06-28: 3.0M2024-07-15: 1.7M2024-07-31: 1.6M2024-08-15: 1.7M2024-08-30: 1.7M2024-09-13: 1.7M2024-09-30: 1.7M2024-10-15: 1.8M2024-10-31: 1.5M2024-11-15: 1.5M2024-11-29: 1.5M2024-12-13: 1.8M2024-12-31: 2.1M2025-01-15: 2.3M2025-01-31: 2.7M2025-02-14: 2.9M2025-02-28: 7.3M2025-03-14: 7.8M2025-03-31: 8.6M2025-04-15: 8.1M2025-04-30: 7.1M2025-05-15: 9.1M2025-05-30: 8.3M
the 30 May 2025 report24 earlier reportsnormal: 1.8M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 26 Jun 2025

Solid Biosciences had 8.1M shares sold short in the 13 Jun 2025 report, 8.9× the same report last year.

This period
8.1M (the 13 Jun 2025 report)
Normal report (median of 24 earlier)
1.9M
Typical spread (median absolute deviation)
426K
How far from its usual level
+9.8
Same report last year
904K
History used
2,690 days
2024-06-14: 904K2024-06-28: 3.0M2024-07-15: 1.7M2024-07-31: 1.6M2024-08-15: 1.7M2024-08-30: 1.7M2024-09-13: 1.7M2024-09-30: 1.7M2024-10-15: 1.8M2024-10-31: 1.5M2024-11-15: 1.5M2024-11-29: 1.5M2024-12-13: 1.8M2024-12-31: 2.1M2025-01-15: 2.3M2025-01-31: 2.7M2025-02-14: 2.9M2025-02-28: 7.3M2025-03-14: 7.8M2025-03-31: 8.6M2025-04-15: 8.1M2025-04-30: 7.1M2025-05-15: 9.1M2025-05-30: 8.3M2025-06-13: 8.1M
the 13 Jun 2025 report24 earlier reportsnormal: 1.9M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 25 Jul 2025

Solid Biosciences had 10.2M shares sold short in the 15 Jul 2025 report, 6.2× the same report last year.

This period
10.2M (the 15 Jul 2025 report)
Normal report (median of 24 earlier)
2.2M
Typical spread (median absolute deviation)
661K
How far from its usual level
+8.2
Same report last year
1.7M
History used
2,722 days
2024-07-15: 1.7M2024-07-31: 1.6M2024-08-15: 1.7M2024-08-30: 1.7M2024-09-13: 1.7M2024-09-30: 1.7M2024-10-15: 1.8M2024-10-31: 1.5M2024-11-15: 1.5M2024-11-29: 1.5M2024-12-13: 1.8M2024-12-31: 2.1M2025-01-15: 2.3M2025-01-31: 2.7M2025-02-14: 2.9M2025-02-28: 7.3M2025-03-14: 7.8M2025-03-31: 8.6M2025-04-15: 8.1M2025-04-30: 7.1M2025-05-15: 9.1M2025-05-30: 8.3M2025-06-13: 8.1M2025-06-30: 10.1M2025-07-15: 10.2M
the 15 Jul 2025 report24 earlier reportsnormal: 2.2M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 12 Aug 2025

Solid Biosciences had 10.1M shares sold short in the 31 Jul 2025 report, 6.3× the same report last year.

This period
10.1M (the 31 Jul 2025 report)
Normal report (median of 24 earlier)
2.5M
Typical spread (median absolute deviation)
957K
How far from its usual level
+5.4
Same report last year
1.6M
History used
2,738 days
2024-07-31: 1.6M2024-08-15: 1.7M2024-08-30: 1.7M2024-09-13: 1.7M2024-09-30: 1.7M2024-10-15: 1.8M2024-10-31: 1.5M2024-11-15: 1.5M2024-11-29: 1.5M2024-12-13: 1.8M2024-12-31: 2.1M2025-01-15: 2.3M2025-01-31: 2.7M2025-02-14: 2.9M2025-02-28: 7.3M2025-03-14: 7.8M2025-03-31: 8.6M2025-04-15: 8.1M2025-04-30: 7.1M2025-05-15: 9.1M2025-05-30: 8.3M2025-06-13: 8.1M2025-06-30: 10.1M2025-07-15: 10.2M2025-07-31: 10.1M
the 31 Jul 2025 report24 earlier reportsnormal: 2.5M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 27 Aug 2025

Solid Biosciences had 9.8M shares sold short in the 15 Aug 2025 report, 5.7× the same report last year.

This period
9.8M (the 15 Aug 2025 report)
Normal report (median of 24 earlier)
2.8M
Typical spread (median absolute deviation)
1.3M
How far from its usual level
+3.6
Same report last year
1.7M
History used
2,753 days
2024-08-15: 1.7M2024-08-30: 1.7M2024-09-13: 1.7M2024-09-30: 1.7M2024-10-15: 1.8M2024-10-31: 1.5M2024-11-15: 1.5M2024-11-29: 1.5M2024-12-13: 1.8M2024-12-31: 2.1M2025-01-15: 2.3M2025-01-31: 2.7M2025-02-14: 2.9M2025-02-28: 7.3M2025-03-14: 7.8M2025-03-31: 8.6M2025-04-15: 8.1M2025-04-30: 7.1M2025-05-15: 9.1M2025-05-30: 8.3M2025-06-13: 8.1M2025-06-30: 10.1M2025-07-15: 10.2M2025-07-31: 10.1M2025-08-15: 9.8M
the 15 Aug 2025 report24 earlier reportsnormal: 2.8M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

21 May 2024confirmed

Confirmed across sources Institutional holdings and Short interest and volume

Solid Biosciences (SLDB): saw 21 13F filers open a new position in the quarter ended 31 Mar 2024, 3.0× the same quarter last year, while it had 3.0M shares sold short in the 28 Jun 2024 report, 70× the same report last year. Two unrelated kinds of activity within 77 days.

  • Short interest and volume: Short interest spike, became public on 25 Apr 2024
  • Short interest and volume: Short interest spike, became public on 10 May 2024
  • Institutional holdings: Many funds opening a new position, became public on 15 May 2024
  • Short interest and volume: Short interest spike, became public on 25 May 2024
  • Short interest and volume: Short interest spike, became public on 12 Jun 2024
  • Short interest and volume: Short interest spike, became public on 11 Jul 2024
2022-03-31: 82022-06-30: 162022-09-30: 62022-12-31: 82023-03-31: 72023-06-30: 22023-09-30: 32023-12-31: 42024-03-31: 21
The quarter ended 31 Mar 2024 against the 8 quarters before it. this quarterearliernormal: 6.5
See the evidence (6 changes)

Short interest and volume: Short interest spike became public on 25 Apr 2024

Solid Biosciences had 1.0M shares sold short in the 15 Apr 2024 report, 23× the same report last year.

This period
1.0M (the 15 Apr 2024 report)
Normal report (median of 24 earlier)
43K
Typical spread (median absolute deviation)
13K
How far from its usual level
+20.1
Same report last year
45K
History used
2,266 days
2023-04-14: 45K2023-04-28: 39K2023-05-15: 41K2023-05-31: 26K2023-06-15: 41K2023-06-30: 44K2023-07-14: 43K2023-07-31: 34K2023-08-15: 43K2023-08-31: 30K2023-09-15: 30K2023-09-29: 30K2023-10-13: 21K2023-10-31: 38K2023-11-15: 36K2023-11-30: 217K2023-12-15: 203K2023-12-29: 248K2024-01-12: 384K2024-01-31: 428K2024-02-15: 607K2024-02-29: 634K2024-03-15: 615K2024-03-28: 921K2024-04-15: 1.0M
the 15 Apr 2024 report24 earlier reportsnormal: 43K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 10 May 2024

Solid Biosciences had 914K shares sold short in the 30 Apr 2024 report, 24× the same report last year.

This period
914K (the 30 Apr 2024 report)
Normal report (median of 24 earlier)
43K
Typical spread (median absolute deviation)
15K
How far from its usual level
+17.4
Same report last year
39K
History used
2,281 days
2023-04-28: 39K2023-05-15: 41K2023-05-31: 26K2023-06-15: 41K2023-06-30: 44K2023-07-14: 43K2023-07-31: 34K2023-08-15: 43K2023-08-31: 30K2023-09-15: 30K2023-09-29: 30K2023-10-13: 21K2023-10-31: 38K2023-11-15: 36K2023-11-30: 217K2023-12-15: 203K2023-12-29: 248K2024-01-12: 384K2024-01-31: 428K2024-02-15: 607K2024-02-29: 634K2024-03-15: 615K2024-03-28: 921K2024-04-15: 1.0M2024-04-30: 914K
the 30 Apr 2024 report24 earlier reportsnormal: 43K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Institutional holdings: Many funds opening a new position became public on 15 May 2024

Solid Biosciences saw 21 13F filers open a new position in the quarter ended 31 Mar 2024, 3.0× the same quarter last year.

This period
21 (the quarter ended 31 Mar 2024)
Normal quarter (median of 8 earlier)
6.5
Typical spread (median absolute deviation)
2
How far from its usual level
+4.8
Same quarter last year
7
History used
2,192 days
2022-03-31: 82022-06-30: 162022-09-30: 62022-12-31: 82023-03-31: 72023-06-30: 22023-09-30: 32023-12-31: 42024-03-31: 21
the quarter ended 31 Mar 20248 earlier quartersnormal: 6.5

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

Check it at the source: SEC Form 13F data sets.

Short interest and volume: Short interest spike became public on 25 May 2024

Solid Biosciences had 929K shares sold short in the 15 May 2024 report, 23× the same report last year.

This period
929K (the 15 May 2024 report)
Normal report (median of 24 earlier)
43K
Typical spread (median absolute deviation)
20K
How far from its usual level
+17.7
Same report last year
41K
History used
2,296 days
2023-05-15: 41K2023-05-31: 26K2023-06-15: 41K2023-06-30: 44K2023-07-14: 43K2023-07-31: 34K2023-08-15: 43K2023-08-31: 30K2023-09-15: 30K2023-09-29: 30K2023-10-13: 21K2023-10-31: 38K2023-11-15: 36K2023-11-30: 217K2023-12-15: 203K2023-12-29: 248K2024-01-12: 384K2024-01-31: 428K2024-02-15: 607K2024-02-29: 634K2024-03-15: 615K2024-03-28: 921K2024-04-15: 1.0M2024-04-30: 914K2024-05-15: 929K
the 15 May 2024 report24 earlier reportsnormal: 43K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 12 Jun 2024

Solid Biosciences had 840K shares sold short in the 31 May 2024 report, 33× the same report last year.

This period
840K (the 31 May 2024 report)
Normal report (median of 24 earlier)
124K
Typical spread (median absolute deviation)
96K
How far from its usual level
+5.0
Same report last year
26K
History used
2,312 days
2023-05-31: 26K2023-06-15: 41K2023-06-30: 44K2023-07-14: 43K2023-07-31: 34K2023-08-15: 43K2023-08-31: 30K2023-09-15: 30K2023-09-29: 30K2023-10-13: 21K2023-10-31: 38K2023-11-15: 36K2023-11-30: 217K2023-12-15: 203K2023-12-29: 248K2024-01-12: 384K2024-01-31: 428K2024-02-15: 607K2024-02-29: 634K2024-03-15: 615K2024-03-28: 921K2024-04-15: 1.0M2024-04-30: 914K2024-05-15: 929K2024-05-31: 840K
the 31 May 2024 report24 earlier reportsnormal: 124K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 11 Jul 2024

Solid Biosciences had 3.0M shares sold short in the 28 Jun 2024 report, 70× the same report last year.

This period
3.0M (the 28 Jun 2024 report)
Normal report (median of 24 earlier)
233K
Typical spread (median absolute deviation)
203K
How far from its usual level
+9.4
Same report last year
44K
History used
2,340 days
2023-06-30: 44K2023-07-14: 43K2023-07-31: 34K2023-08-15: 43K2023-08-31: 30K2023-09-15: 30K2023-09-29: 30K2023-10-13: 21K2023-10-31: 38K2023-11-15: 36K2023-11-30: 217K2023-12-15: 203K2023-12-29: 248K2024-01-12: 384K2024-01-31: 428K2024-02-15: 607K2024-02-29: 634K2024-03-15: 615K2024-03-28: 921K2024-04-15: 1.0M2024-04-30: 914K2024-05-15: 929K2024-05-31: 840K2024-06-14: 904K2024-06-28: 3.0M
the 28 Jun 2024 report24 earlier reportsnormal: 233K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

Timeline

Changes and notable records, by the date each became public

  1. 25 Sep 2026Short interest and volume change

    had 17.1M shares sold short in the 15 Sep 2026 report, 1.7× the same report last year.

    Same report last year: 9.9M; its normal report is 9.8M.

    See the evidence
    This period
    17.1M (the 15 Sep 2026 report)
    Normal report (median of 24 earlier)
    9.8M
    Typical spread (median absolute deviation)
    558K
    How far from its usual level
    +7.4
    Same report last year
    9.9M
    History used
    3,149 days
    2025-09-15: 9.9M2025-09-30: 10.2M2025-10-15: 9.6M2025-10-31: 8.9M2025-11-14: 9.6M2025-11-28: 10.5M2025-12-15: 9.9M2025-12-31: 10.0M2026-01-15: 8.6M2026-01-30: 8.7M2026-02-13: 9.4M2026-02-27: 9.5M2026-03-13: 9.8M2026-03-31: 10.0M2026-04-15: 9.4M2026-04-30: 8.8M2026-05-15: 9.1M2026-05-29: 9.6M2026-06-15: 11.6M2026-06-30: 18.3M2026-07-15: 17.7M2026-07-31: 17.0M2026-08-14: 16.6M2026-08-31: 16.4M2026-09-15: 17.1M
    the 15 Sep 2026 report24 earlier reportsnormal: 9.8M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  2. 11 Sep 2026Short interest and volume change

    had 16.4M shares sold short in the 31 Aug 2026 report, 1.7× the same report last year.

    Same report last year: 9.8M; its normal report is 9.8M.

    See the evidence
    This period
    16.4M (the 31 Aug 2026 report)
    Normal report (median of 24 earlier)
    9.8M
    Typical spread (median absolute deviation)
    378K
    How far from its usual level
    +6.7
    Same report last year
    9.8M
    History used
    3,134 days
    2025-08-29: 9.8M2025-09-15: 9.9M2025-09-30: 10.2M2025-10-15: 9.6M2025-10-31: 8.9M2025-11-14: 9.6M2025-11-28: 10.5M2025-12-15: 9.9M2025-12-31: 10.0M2026-01-15: 8.6M2026-01-30: 8.7M2026-02-13: 9.4M2026-02-27: 9.5M2026-03-13: 9.8M2026-03-31: 10.0M2026-04-15: 9.4M2026-04-30: 8.8M2026-05-15: 9.1M2026-05-29: 9.6M2026-06-15: 11.6M2026-06-30: 18.3M2026-07-15: 17.7M2026-07-31: 17.0M2026-08-14: 16.6M2026-08-31: 16.4M
    the 31 Aug 2026 report24 earlier reportsnormal: 9.8M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  3. 26 Aug 2026Short interest and volume change

    had 16.6M shares sold short in the 14 Aug 2026 report, 1.7× the same report last year.

    Same report last year: 9.8M; its normal report is 9.8M.

    See the evidence
    This period
    16.6M (the 14 Aug 2026 report)
    Normal report (median of 24 earlier)
    9.8M
    Typical spread (median absolute deviation)
    333K
    How far from its usual level
    +7.0
    Same report last year
    9.8M
    History used
    3,117 days
    2025-08-15: 9.8M2025-08-29: 9.8M2025-09-15: 9.9M2025-09-30: 10.2M2025-10-15: 9.6M2025-10-31: 8.9M2025-11-14: 9.6M2025-11-28: 10.5M2025-12-15: 9.9M2025-12-31: 10.0M2026-01-15: 8.6M2026-01-30: 8.7M2026-02-13: 9.4M2026-02-27: 9.5M2026-03-13: 9.8M2026-03-31: 10.0M2026-04-15: 9.4M2026-04-30: 8.8M2026-05-15: 9.1M2026-05-29: 9.6M2026-06-15: 11.6M2026-06-30: 18.3M2026-07-15: 17.7M2026-07-31: 17.0M2026-08-14: 16.6M
    the 14 Aug 2026 report24 earlier reportsnormal: 9.8M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  4. 12 Aug 2026Short interest and volume change

    had 17.0M shares sold short in the 31 Jul 2026 report, 1.7× the same report last year.

    Same report last year: 10.1M; its normal report is 9.8M.

    See the evidence
    This period
    17.0M (the 31 Jul 2026 report)
    Normal report (median of 24 earlier)
    9.8M
    Typical spread (median absolute deviation)
    333K
    How far from its usual level
    +7.4
    Same report last year
    10.1M
    History used
    3,103 days
    2025-07-31: 10.1M2025-08-15: 9.8M2025-08-29: 9.8M2025-09-15: 9.9M2025-09-30: 10.2M2025-10-15: 9.6M2025-10-31: 8.9M2025-11-14: 9.6M2025-11-28: 10.5M2025-12-15: 9.9M2025-12-31: 10.0M2026-01-15: 8.6M2026-01-30: 8.7M2026-02-13: 9.4M2026-02-27: 9.5M2026-03-13: 9.8M2026-03-31: 10.0M2026-04-15: 9.4M2026-04-30: 8.8M2026-05-15: 9.1M2026-05-29: 9.6M2026-06-15: 11.6M2026-06-30: 18.3M2026-07-15: 17.7M2026-07-31: 17.0M
    the 31 Jul 2026 report24 earlier reportsnormal: 9.8M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  5. 10 Apr 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  6. 10 Apr 2026Filings record

    Director or officer change

  7. 27 Aug 2025Short interest and volume change

    had 9.8M shares sold short in the 15 Aug 2025 report, 5.7× the same report last year.

    Same report last year: 1.7M; its normal report is 2.8M.

    See the evidence
    This period
    9.8M (the 15 Aug 2025 report)
    Normal report (median of 24 earlier)
    2.8M
    Typical spread (median absolute deviation)
    1.3M
    How far from its usual level
    +3.6
    Same report last year
    1.7M
    History used
    2,753 days
    2024-08-15: 1.7M2024-08-30: 1.7M2024-09-13: 1.7M2024-09-30: 1.7M2024-10-15: 1.8M2024-10-31: 1.5M2024-11-15: 1.5M2024-11-29: 1.5M2024-12-13: 1.8M2024-12-31: 2.1M2025-01-15: 2.3M2025-01-31: 2.7M2025-02-14: 2.9M2025-02-28: 7.3M2025-03-14: 7.8M2025-03-31: 8.6M2025-04-15: 8.1M2025-04-30: 7.1M2025-05-15: 9.1M2025-05-30: 8.3M2025-06-13: 8.1M2025-06-30: 10.1M2025-07-15: 10.2M2025-07-31: 10.1M2025-08-15: 9.8M
    the 15 Aug 2025 report24 earlier reportsnormal: 2.8M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  8. 12 Aug 2025Short interest and volume change

    had 10.1M shares sold short in the 31 Jul 2025 report, 6.3× the same report last year.

    Same report last year: 1.6M; its normal report is 2.5M.

    See the evidence
    This period
    10.1M (the 31 Jul 2025 report)
    Normal report (median of 24 earlier)
    2.5M
    Typical spread (median absolute deviation)
    957K
    How far from its usual level
    +5.4
    Same report last year
    1.6M
    History used
    2,738 days
    2024-07-31: 1.6M2024-08-15: 1.7M2024-08-30: 1.7M2024-09-13: 1.7M2024-09-30: 1.7M2024-10-15: 1.8M2024-10-31: 1.5M2024-11-15: 1.5M2024-11-29: 1.5M2024-12-13: 1.8M2024-12-31: 2.1M2025-01-15: 2.3M2025-01-31: 2.7M2025-02-14: 2.9M2025-02-28: 7.3M2025-03-14: 7.8M2025-03-31: 8.6M2025-04-15: 8.1M2025-04-30: 7.1M2025-05-15: 9.1M2025-05-30: 8.3M2025-06-13: 8.1M2025-06-30: 10.1M2025-07-15: 10.2M2025-07-31: 10.1M
    the 31 Jul 2025 report24 earlier reportsnormal: 2.5M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  9. 25 Jul 2025Short interest and volume change

    had 10.2M shares sold short in the 15 Jul 2025 report, 6.2× the same report last year.

    Same report last year: 1.7M; its normal report is 2.2M.

    See the evidence
    This period
    10.2M (the 15 Jul 2025 report)
    Normal report (median of 24 earlier)
    2.2M
    Typical spread (median absolute deviation)
    661K
    How far from its usual level
    +8.2
    Same report last year
    1.7M
    History used
    2,722 days
    2024-07-15: 1.7M2024-07-31: 1.6M2024-08-15: 1.7M2024-08-30: 1.7M2024-09-13: 1.7M2024-09-30: 1.7M2024-10-15: 1.8M2024-10-31: 1.5M2024-11-15: 1.5M2024-11-29: 1.5M2024-12-13: 1.8M2024-12-31: 2.1M2025-01-15: 2.3M2025-01-31: 2.7M2025-02-14: 2.9M2025-02-28: 7.3M2025-03-14: 7.8M2025-03-31: 8.6M2025-04-15: 8.1M2025-04-30: 7.1M2025-05-15: 9.1M2025-05-30: 8.3M2025-06-13: 8.1M2025-06-30: 10.1M2025-07-15: 10.2M
    the 15 Jul 2025 report24 earlier reportsnormal: 2.2M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  10. 26 Jun 2025Short interest and volume change

    had 8.1M shares sold short in the 13 Jun 2025 report, 8.9× the same report last year.

    Same report last year: 904K; its normal report is 1.9M.

    See the evidence
    This period
    8.1M (the 13 Jun 2025 report)
    Normal report (median of 24 earlier)
    1.9M
    Typical spread (median absolute deviation)
    426K
    How far from its usual level
    +9.8
    Same report last year
    904K
    History used
    2,690 days
    2024-06-14: 904K2024-06-28: 3.0M2024-07-15: 1.7M2024-07-31: 1.6M2024-08-15: 1.7M2024-08-30: 1.7M2024-09-13: 1.7M2024-09-30: 1.7M2024-10-15: 1.8M2024-10-31: 1.5M2024-11-15: 1.5M2024-11-29: 1.5M2024-12-13: 1.8M2024-12-31: 2.1M2025-01-15: 2.3M2025-01-31: 2.7M2025-02-14: 2.9M2025-02-28: 7.3M2025-03-14: 7.8M2025-03-31: 8.6M2025-04-15: 8.1M2025-04-30: 7.1M2025-05-15: 9.1M2025-05-30: 8.3M2025-06-13: 8.1M
    the 13 Jun 2025 report24 earlier reportsnormal: 1.9M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  11. 13 Jun 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  12. 13 Jun 2025Filings record

    Director or officer change

  13. 11 Jun 2025Short interest and volume change

    had 8.3M shares sold short in the 30 May 2025 report, 9.9× the same report last year.

    Same report last year: 840K; its normal report is 1.8M.

    See the evidence
    This period
    8.3M (the 30 May 2025 report)
    Normal report (median of 24 earlier)
    1.8M
    Typical spread (median absolute deviation)
    432K
    How far from its usual level
    +10.3
    Same report last year
    840K
    History used
    2,676 days
    2024-05-31: 840K2024-06-14: 904K2024-06-28: 3.0M2024-07-15: 1.7M2024-07-31: 1.6M2024-08-15: 1.7M2024-08-30: 1.7M2024-09-13: 1.7M2024-09-30: 1.7M2024-10-15: 1.8M2024-10-31: 1.5M2024-11-15: 1.5M2024-11-29: 1.5M2024-12-13: 1.8M2024-12-31: 2.1M2025-01-15: 2.3M2025-01-31: 2.7M2025-02-14: 2.9M2025-02-28: 7.3M2025-03-14: 7.8M2025-03-31: 8.6M2025-04-15: 8.1M2025-04-30: 7.1M2025-05-15: 9.1M2025-05-30: 8.3M
    the 30 May 2025 report24 earlier reportsnormal: 1.8M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  14. 28 May 2025Short interest and volume change

    had 9.1M shares sold short in the 15 May 2025 report, 9.7× the same report last year.

    Same report last year: 929K; its normal report is 1.7M.

    See the evidence
    This period
    9.1M (the 15 May 2025 report)
    Normal report (median of 24 earlier)
    1.7M
    Typical spread (median absolute deviation)
    453K
    How far from its usual level
    +10.9
    Same report last year
    929K
    History used
    2,661 days
    2024-05-15: 929K2024-05-31: 840K2024-06-14: 904K2024-06-28: 3.0M2024-07-15: 1.7M2024-07-31: 1.6M2024-08-15: 1.7M2024-08-30: 1.7M2024-09-13: 1.7M2024-09-30: 1.7M2024-10-15: 1.8M2024-10-31: 1.5M2024-11-15: 1.5M2024-11-29: 1.5M2024-12-13: 1.8M2024-12-31: 2.1M2025-01-15: 2.3M2025-01-31: 2.7M2025-02-14: 2.9M2025-02-28: 7.3M2025-03-14: 7.8M2025-03-31: 8.6M2025-04-15: 8.1M2025-04-30: 7.1M2025-05-15: 9.1M
    the 15 May 2025 report24 earlier reportsnormal: 1.7M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  15. 15 May 2025Institutional holdings change

    saw 51 13F filers open a new position in the quarter ended 31 Mar 2025, 2.4× the same quarter last year.

    Same quarter last year: 21; its normal quarter is 9.

    See the evidence
    This period
    51 (the quarter ended 31 Mar 2025)
    Normal quarter (median of 8 earlier)
    9
    Typical spread (median absolute deviation)
    6.5
    How far from its usual level
    +4.4
    Same quarter last year
    21
    History used
    2,557 days
    2023-03-31: 72023-06-30: 22023-09-30: 32023-12-31: 42024-03-31: 212024-06-30: 272024-09-30: 232024-12-31: 112025-03-31: 51
    the quarter ended 31 Mar 20258 earlier quartersnormal: 9

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  16. 10 May 2025Short interest and volume change

    had 7.1M shares sold short in the 30 Apr 2025 report, 7.8× the same report last year.

    Same report last year: 914K; its normal report is 1.7M.

    See the evidence
    This period
    7.1M (the 30 Apr 2025 report)
    Normal report (median of 24 earlier)
    1.7M
    Typical spread (median absolute deviation)
    468K
    How far from its usual level
    +7.7
    Same report last year
    914K
    History used
    2,646 days
    2024-04-30: 914K2024-05-15: 929K2024-05-31: 840K2024-06-14: 904K2024-06-28: 3.0M2024-07-15: 1.7M2024-07-31: 1.6M2024-08-15: 1.7M2024-08-30: 1.7M2024-09-13: 1.7M2024-09-30: 1.7M2024-10-15: 1.8M2024-10-31: 1.5M2024-11-15: 1.5M2024-11-29: 1.5M2024-12-13: 1.8M2024-12-31: 2.1M2025-01-15: 2.3M2025-01-31: 2.7M2025-02-14: 2.9M2025-02-28: 7.3M2025-03-14: 7.8M2025-03-31: 8.6M2025-04-15: 8.1M2025-04-30: 7.1M
    the 30 Apr 2025 report24 earlier reportsnormal: 1.7M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  17. 26 Apr 2025Short interest and volume change

    had 8.1M shares sold short in the 15 Apr 2025 report, 7.7× the same report last year.

    Same report last year: 1.0M; its normal report is 1.7M.

    See the evidence
    This period
    8.1M (the 15 Apr 2025 report)
    Normal report (median of 24 earlier)
    1.7M
    Typical spread (median absolute deviation)
    488K
    How far from its usual level
    +8.8
    Same report last year
    1.0M
    History used
    2,631 days
    2024-04-15: 1.0M2024-04-30: 914K2024-05-15: 929K2024-05-31: 840K2024-06-14: 904K2024-06-28: 3.0M2024-07-15: 1.7M2024-07-31: 1.6M2024-08-15: 1.7M2024-08-30: 1.7M2024-09-13: 1.7M2024-09-30: 1.7M2024-10-15: 1.8M2024-10-31: 1.5M2024-11-15: 1.5M2024-11-29: 1.5M2024-12-13: 1.8M2024-12-31: 2.1M2025-01-15: 2.3M2025-01-31: 2.7M2025-02-14: 2.9M2025-02-28: 7.3M2025-03-14: 7.8M2025-03-31: 8.6M2025-04-15: 8.1M
    the 15 Apr 2025 report24 earlier reportsnormal: 1.7M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  18. 10 Apr 2025Short interest and volume change

    had 8.6M shares sold short in the 31 Mar 2025 report, 9.4× the same report last year.

    Same report last year: 921K; its normal report is 1.7M.

    See the evidence
    This period
    8.6M (the 31 Mar 2025 report)
    Normal report (median of 24 earlier)
    1.7M
    Typical spread (median absolute deviation)
    505K
    How far from its usual level
    +9.3
    Same report last year
    921K
    History used
    2,616 days
    2024-03-28: 921K2024-04-15: 1.0M2024-04-30: 914K2024-05-15: 929K2024-05-31: 840K2024-06-14: 904K2024-06-28: 3.0M2024-07-15: 1.7M2024-07-31: 1.6M2024-08-15: 1.7M2024-08-30: 1.7M2024-09-13: 1.7M2024-09-30: 1.7M2024-10-15: 1.8M2024-10-31: 1.5M2024-11-15: 1.5M2024-11-29: 1.5M2024-12-13: 1.8M2024-12-31: 2.1M2025-01-15: 2.3M2025-01-31: 2.7M2025-02-14: 2.9M2025-02-28: 7.3M2025-03-14: 7.8M2025-03-31: 8.6M
    the 31 Mar 2025 report24 earlier reportsnormal: 1.7M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  19. 26 Mar 2025Short interest and volume change

    had 7.8M shares sold short in the 14 Mar 2025 report, 13× the same report last year.

    Same report last year: 615K; its normal report is 1.7M.

    See the evidence
    This period
    7.8M (the 14 Mar 2025 report)
    Normal report (median of 24 earlier)
    1.7M
    Typical spread (median absolute deviation)
    505K
    How far from its usual level
    +8.3
    Same report last year
    615K
    History used
    2,599 days
    2024-03-15: 615K2024-03-28: 921K2024-04-15: 1.0M2024-04-30: 914K2024-05-15: 929K2024-05-31: 840K2024-06-14: 904K2024-06-28: 3.0M2024-07-15: 1.7M2024-07-31: 1.6M2024-08-15: 1.7M2024-08-30: 1.7M2024-09-13: 1.7M2024-09-30: 1.7M2024-10-15: 1.8M2024-10-31: 1.5M2024-11-15: 1.5M2024-11-29: 1.5M2024-12-13: 1.8M2024-12-31: 2.1M2025-01-15: 2.3M2025-01-31: 2.7M2025-02-14: 2.9M2025-02-28: 7.3M2025-03-14: 7.8M
    the 14 Mar 2025 report24 earlier reportsnormal: 1.7M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  20. 18 Mar 2025several at once

    had 3 insiders buy $26.1M of its shares on the open market within 30 days (3 filings); it also saw 51 13F filers open a new position in the quarter ended 31 Mar 2025, 2.4× the same quarter last year; and it had 10.2M shares sold short in the 15 Jul 2025 report, 6.2× the same report last year. Three unrelated kinds of activity within 192 days.

    See the evidence (13 changes)

    Insiders: Clustered insider buying became public on 22 Feb 2025

    Solid Biosciences had 3 insiders buy $26.1M of its shares on the open market within 30 days (3 filings).

    Independent buyers
    3
    Purchase filings (Form 4, code P)
    3
    Total bought
    $26.1M
    Window
    23 Jan 2025 to 22 Feb 2025

    Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

    Short interest and volume: Short interest spike became public on 12 Mar 2025

    Solid Biosciences had 7.3M shares sold short in the 28 Feb 2025 report, 12× the same report last year.

    This period
    7.3M (the 28 Feb 2025 report)
    Normal report (median of 24 earlier)
    1.6M
    Typical spread (median absolute deviation)
    505K
    How far from its usual level
    +7.6
    Same report last year
    634K
    History used
    2,585 days
    2024-02-29: 634K2024-03-15: 615K2024-03-28: 921K2024-04-15: 1.0M2024-04-30: 914K2024-05-15: 929K2024-05-31: 840K2024-06-14: 904K2024-06-28: 3.0M2024-07-15: 1.7M2024-07-31: 1.6M2024-08-15: 1.7M2024-08-30: 1.7M2024-09-13: 1.7M2024-09-30: 1.7M2024-10-15: 1.8M2024-10-31: 1.5M2024-11-15: 1.5M2024-11-29: 1.5M2024-12-13: 1.8M2024-12-31: 2.1M2025-01-15: 2.3M2025-01-31: 2.7M2025-02-14: 2.9M2025-02-28: 7.3M
    the 28 Feb 2025 report24 earlier reportsnormal: 1.6M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 26 Mar 2025

    Solid Biosciences had 7.8M shares sold short in the 14 Mar 2025 report, 13× the same report last year.

    This period
    7.8M (the 14 Mar 2025 report)
    Normal report (median of 24 earlier)
    1.7M
    Typical spread (median absolute deviation)
    505K
    How far from its usual level
    +8.3
    Same report last year
    615K
    History used
    2,599 days
    2024-03-15: 615K2024-03-28: 921K2024-04-15: 1.0M2024-04-30: 914K2024-05-15: 929K2024-05-31: 840K2024-06-14: 904K2024-06-28: 3.0M2024-07-15: 1.7M2024-07-31: 1.6M2024-08-15: 1.7M2024-08-30: 1.7M2024-09-13: 1.7M2024-09-30: 1.7M2024-10-15: 1.8M2024-10-31: 1.5M2024-11-15: 1.5M2024-11-29: 1.5M2024-12-13: 1.8M2024-12-31: 2.1M2025-01-15: 2.3M2025-01-31: 2.7M2025-02-14: 2.9M2025-02-28: 7.3M2025-03-14: 7.8M
    the 14 Mar 2025 report24 earlier reportsnormal: 1.7M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 10 Apr 2025

    Solid Biosciences had 8.6M shares sold short in the 31 Mar 2025 report, 9.4× the same report last year.

    This period
    8.6M (the 31 Mar 2025 report)
    Normal report (median of 24 earlier)
    1.7M
    Typical spread (median absolute deviation)
    505K
    How far from its usual level
    +9.3
    Same report last year
    921K
    History used
    2,616 days
    2024-03-28: 921K2024-04-15: 1.0M2024-04-30: 914K2024-05-15: 929K2024-05-31: 840K2024-06-14: 904K2024-06-28: 3.0M2024-07-15: 1.7M2024-07-31: 1.6M2024-08-15: 1.7M2024-08-30: 1.7M2024-09-13: 1.7M2024-09-30: 1.7M2024-10-15: 1.8M2024-10-31: 1.5M2024-11-15: 1.5M2024-11-29: 1.5M2024-12-13: 1.8M2024-12-31: 2.1M2025-01-15: 2.3M2025-01-31: 2.7M2025-02-14: 2.9M2025-02-28: 7.3M2025-03-14: 7.8M2025-03-31: 8.6M
    the 31 Mar 2025 report24 earlier reportsnormal: 1.7M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 26 Apr 2025

    Solid Biosciences had 8.1M shares sold short in the 15 Apr 2025 report, 7.7× the same report last year.

    This period
    8.1M (the 15 Apr 2025 report)
    Normal report (median of 24 earlier)
    1.7M
    Typical spread (median absolute deviation)
    488K
    How far from its usual level
    +8.8
    Same report last year
    1.0M
    History used
    2,631 days
    2024-04-15: 1.0M2024-04-30: 914K2024-05-15: 929K2024-05-31: 840K2024-06-14: 904K2024-06-28: 3.0M2024-07-15: 1.7M2024-07-31: 1.6M2024-08-15: 1.7M2024-08-30: 1.7M2024-09-13: 1.7M2024-09-30: 1.7M2024-10-15: 1.8M2024-10-31: 1.5M2024-11-15: 1.5M2024-11-29: 1.5M2024-12-13: 1.8M2024-12-31: 2.1M2025-01-15: 2.3M2025-01-31: 2.7M2025-02-14: 2.9M2025-02-28: 7.3M2025-03-14: 7.8M2025-03-31: 8.6M2025-04-15: 8.1M
    the 15 Apr 2025 report24 earlier reportsnormal: 1.7M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 10 May 2025

    Solid Biosciences had 7.1M shares sold short in the 30 Apr 2025 report, 7.8× the same report last year.

    This period
    7.1M (the 30 Apr 2025 report)
    Normal report (median of 24 earlier)
    1.7M
    Typical spread (median absolute deviation)
    468K
    How far from its usual level
    +7.7
    Same report last year
    914K
    History used
    2,646 days
    2024-04-30: 914K2024-05-15: 929K2024-05-31: 840K2024-06-14: 904K2024-06-28: 3.0M2024-07-15: 1.7M2024-07-31: 1.6M2024-08-15: 1.7M2024-08-30: 1.7M2024-09-13: 1.7M2024-09-30: 1.7M2024-10-15: 1.8M2024-10-31: 1.5M2024-11-15: 1.5M2024-11-29: 1.5M2024-12-13: 1.8M2024-12-31: 2.1M2025-01-15: 2.3M2025-01-31: 2.7M2025-02-14: 2.9M2025-02-28: 7.3M2025-03-14: 7.8M2025-03-31: 8.6M2025-04-15: 8.1M2025-04-30: 7.1M
    the 30 Apr 2025 report24 earlier reportsnormal: 1.7M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Institutional holdings: Many funds opening a new position became public on 15 May 2025

    Solid Biosciences saw 51 13F filers open a new position in the quarter ended 31 Mar 2025, 2.4× the same quarter last year.

    This period
    51 (the quarter ended 31 Mar 2025)
    Normal quarter (median of 8 earlier)
    9
    Typical spread (median absolute deviation)
    6.5
    How far from its usual level
    +4.4
    Same quarter last year
    21
    History used
    2,557 days
    2023-03-31: 72023-06-30: 22023-09-30: 32023-12-31: 42024-03-31: 212024-06-30: 272024-09-30: 232024-12-31: 112025-03-31: 51
    the quarter ended 31 Mar 20258 earlier quartersnormal: 9

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

    Short interest and volume: Short interest spike became public on 28 May 2025

    Solid Biosciences had 9.1M shares sold short in the 15 May 2025 report, 9.7× the same report last year.

    This period
    9.1M (the 15 May 2025 report)
    Normal report (median of 24 earlier)
    1.7M
    Typical spread (median absolute deviation)
    453K
    How far from its usual level
    +10.9
    Same report last year
    929K
    History used
    2,661 days
    2024-05-15: 929K2024-05-31: 840K2024-06-14: 904K2024-06-28: 3.0M2024-07-15: 1.7M2024-07-31: 1.6M2024-08-15: 1.7M2024-08-30: 1.7M2024-09-13: 1.7M2024-09-30: 1.7M2024-10-15: 1.8M2024-10-31: 1.5M2024-11-15: 1.5M2024-11-29: 1.5M2024-12-13: 1.8M2024-12-31: 2.1M2025-01-15: 2.3M2025-01-31: 2.7M2025-02-14: 2.9M2025-02-28: 7.3M2025-03-14: 7.8M2025-03-31: 8.6M2025-04-15: 8.1M2025-04-30: 7.1M2025-05-15: 9.1M
    the 15 May 2025 report24 earlier reportsnormal: 1.7M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 11 Jun 2025

    Solid Biosciences had 8.3M shares sold short in the 30 May 2025 report, 9.9× the same report last year.

    This period
    8.3M (the 30 May 2025 report)
    Normal report (median of 24 earlier)
    1.8M
    Typical spread (median absolute deviation)
    432K
    How far from its usual level
    +10.3
    Same report last year
    840K
    History used
    2,676 days
    2024-05-31: 840K2024-06-14: 904K2024-06-28: 3.0M2024-07-15: 1.7M2024-07-31: 1.6M2024-08-15: 1.7M2024-08-30: 1.7M2024-09-13: 1.7M2024-09-30: 1.7M2024-10-15: 1.8M2024-10-31: 1.5M2024-11-15: 1.5M2024-11-29: 1.5M2024-12-13: 1.8M2024-12-31: 2.1M2025-01-15: 2.3M2025-01-31: 2.7M2025-02-14: 2.9M2025-02-28: 7.3M2025-03-14: 7.8M2025-03-31: 8.6M2025-04-15: 8.1M2025-04-30: 7.1M2025-05-15: 9.1M2025-05-30: 8.3M
    the 30 May 2025 report24 earlier reportsnormal: 1.8M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 26 Jun 2025

    Solid Biosciences had 8.1M shares sold short in the 13 Jun 2025 report, 8.9× the same report last year.

    This period
    8.1M (the 13 Jun 2025 report)
    Normal report (median of 24 earlier)
    1.9M
    Typical spread (median absolute deviation)
    426K
    How far from its usual level
    +9.8
    Same report last year
    904K
    History used
    2,690 days
    2024-06-14: 904K2024-06-28: 3.0M2024-07-15: 1.7M2024-07-31: 1.6M2024-08-15: 1.7M2024-08-30: 1.7M2024-09-13: 1.7M2024-09-30: 1.7M2024-10-15: 1.8M2024-10-31: 1.5M2024-11-15: 1.5M2024-11-29: 1.5M2024-12-13: 1.8M2024-12-31: 2.1M2025-01-15: 2.3M2025-01-31: 2.7M2025-02-14: 2.9M2025-02-28: 7.3M2025-03-14: 7.8M2025-03-31: 8.6M2025-04-15: 8.1M2025-04-30: 7.1M2025-05-15: 9.1M2025-05-30: 8.3M2025-06-13: 8.1M
    the 13 Jun 2025 report24 earlier reportsnormal: 1.9M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 25 Jul 2025

    Solid Biosciences had 10.2M shares sold short in the 15 Jul 2025 report, 6.2× the same report last year.

    This period
    10.2M (the 15 Jul 2025 report)
    Normal report (median of 24 earlier)
    2.2M
    Typical spread (median absolute deviation)
    661K
    How far from its usual level
    +8.2
    Same report last year
    1.7M
    History used
    2,722 days
    2024-07-15: 1.7M2024-07-31: 1.6M2024-08-15: 1.7M2024-08-30: 1.7M2024-09-13: 1.7M2024-09-30: 1.7M2024-10-15: 1.8M2024-10-31: 1.5M2024-11-15: 1.5M2024-11-29: 1.5M2024-12-13: 1.8M2024-12-31: 2.1M2025-01-15: 2.3M2025-01-31: 2.7M2025-02-14: 2.9M2025-02-28: 7.3M2025-03-14: 7.8M2025-03-31: 8.6M2025-04-15: 8.1M2025-04-30: 7.1M2025-05-15: 9.1M2025-05-30: 8.3M2025-06-13: 8.1M2025-06-30: 10.1M2025-07-15: 10.2M
    the 15 Jul 2025 report24 earlier reportsnormal: 2.2M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 12 Aug 2025

    Solid Biosciences had 10.1M shares sold short in the 31 Jul 2025 report, 6.3× the same report last year.

    This period
    10.1M (the 31 Jul 2025 report)
    Normal report (median of 24 earlier)
    2.5M
    Typical spread (median absolute deviation)
    957K
    How far from its usual level
    +5.4
    Same report last year
    1.6M
    History used
    2,738 days
    2024-07-31: 1.6M2024-08-15: 1.7M2024-08-30: 1.7M2024-09-13: 1.7M2024-09-30: 1.7M2024-10-15: 1.8M2024-10-31: 1.5M2024-11-15: 1.5M2024-11-29: 1.5M2024-12-13: 1.8M2024-12-31: 2.1M2025-01-15: 2.3M2025-01-31: 2.7M2025-02-14: 2.9M2025-02-28: 7.3M2025-03-14: 7.8M2025-03-31: 8.6M2025-04-15: 8.1M2025-04-30: 7.1M2025-05-15: 9.1M2025-05-30: 8.3M2025-06-13: 8.1M2025-06-30: 10.1M2025-07-15: 10.2M2025-07-31: 10.1M
    the 31 Jul 2025 report24 earlier reportsnormal: 2.5M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 27 Aug 2025

    Solid Biosciences had 9.8M shares sold short in the 15 Aug 2025 report, 5.7× the same report last year.

    This period
    9.8M (the 15 Aug 2025 report)
    Normal report (median of 24 earlier)
    2.8M
    Typical spread (median absolute deviation)
    1.3M
    How far from its usual level
    +3.6
    Same report last year
    1.7M
    History used
    2,753 days
    2024-08-15: 1.7M2024-08-30: 1.7M2024-09-13: 1.7M2024-09-30: 1.7M2024-10-15: 1.8M2024-10-31: 1.5M2024-11-15: 1.5M2024-11-29: 1.5M2024-12-13: 1.8M2024-12-31: 2.1M2025-01-15: 2.3M2025-01-31: 2.7M2025-02-14: 2.9M2025-02-28: 7.3M2025-03-14: 7.8M2025-03-31: 8.6M2025-04-15: 8.1M2025-04-30: 7.1M2025-05-15: 9.1M2025-05-30: 8.3M2025-06-13: 8.1M2025-06-30: 10.1M2025-07-15: 10.2M2025-07-31: 10.1M2025-08-15: 9.8M
    the 15 Aug 2025 report24 earlier reportsnormal: 2.8M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

  21. 14 Mar 2025Insiders record

    Kahn Clare (director) bought 1,860 shares of SLDB ($9,932) (dated 13 Mar 2025)

  22. 12 Mar 2025Short interest and volume change

    had 7.3M shares sold short in the 28 Feb 2025 report, 12× the same report last year.

    Same report last year: 634K; its normal report is 1.6M.

    See the evidence
    This period
    7.3M (the 28 Feb 2025 report)
    Normal report (median of 24 earlier)
    1.6M
    Typical spread (median absolute deviation)
    505K
    How far from its usual level
    +7.6
    Same report last year
    634K
    History used
    2,585 days
    2024-02-29: 634K2024-03-15: 615K2024-03-28: 921K2024-04-15: 1.0M2024-04-30: 914K2024-05-15: 929K2024-05-31: 840K2024-06-14: 904K2024-06-28: 3.0M2024-07-15: 1.7M2024-07-31: 1.6M2024-08-15: 1.7M2024-08-30: 1.7M2024-09-13: 1.7M2024-09-30: 1.7M2024-10-15: 1.8M2024-10-31: 1.5M2024-11-15: 1.5M2024-11-29: 1.5M2024-12-13: 1.8M2024-12-31: 2.1M2025-01-15: 2.3M2025-01-31: 2.7M2025-02-14: 2.9M2025-02-28: 7.3M
    the 28 Feb 2025 report24 earlier reportsnormal: 1.6M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  23. 22 Feb 2025Insiders change

    had 3 insiders buy $26.1M of its shares on the open market within 30 days (3 filings).

    See the evidence (3 source records)
    Independent buyers
    3
    Purchase filings (Form 4, code P)
    3
    Total bought
    $26.1M
    Window
    23 Jan 2025 to 22 Feb 2025

    Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

  24. 22 Feb 2025Insiders record

    EDELMAN JOSEPH (director) and 3 other(s) bought 5,000,000 shares of SLDB ($20.1M) (dated 21 Feb 2025)

  25. 22 Feb 2025Insiders record

    BCLS SB Investco, LP (ten percent owner) and 9 other(s) bought 1,000,000 shares of SLDB ($4.0M) (dated 21 Feb 2025)

  26. 20 Feb 2025Insiders record

    Atchinson Robert (ten percent owner) and 2 other(s) bought 252,545 shares of SLDB ($1.9M) (dated 19 Feb 2025)

  27. 14 Nov 2024Institutional holdings change

    saw 23 13F filers open a new position in the quarter ended 30 Sep 2024, 7.7× the same quarter last year.

    Same quarter last year: 3; its normal quarter is 6.5.

    See the evidence
    This period
    23 (the quarter ended 30 Sep 2024)
    Normal quarter (median of 8 earlier)
    6.5
    Typical spread (median absolute deviation)
    3
    How far from its usual level
    +3.7
    Same quarter last year
    3
    History used
    2,375 days
    2022-09-30: 62022-12-31: 82023-03-31: 72023-06-30: 22023-09-30: 32023-12-31: 42024-03-31: 212024-06-30: 272024-09-30: 23
    the quarter ended 30 Sep 20248 earlier quartersnormal: 6.5

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  28. 14 Aug 2024Institutional holdings change

    saw 27 13F filers open a new position in the quarter ended 30 Jun 2024, 14× the same quarter last year.

    Same quarter last year: 2; its normal quarter is 6.5.

    See the evidence
    This period
    27 (the quarter ended 30 Jun 2024)
    Normal quarter (median of 8 earlier)
    6.5
    Typical spread (median absolute deviation)
    3
    How far from its usual level
    +4.6
    Same quarter last year
    2
    History used
    2,283 days
    2022-06-30: 162022-09-30: 62022-12-31: 82023-03-31: 72023-06-30: 22023-09-30: 32023-12-31: 42024-03-31: 212024-06-30: 27
    the quarter ended 30 Jun 20248 earlier quartersnormal: 6.5

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  29. 11 Jul 2024Short interest and volume change

    had 3.0M shares sold short in the 28 Jun 2024 report, 70× the same report last year.

    Same report last year: 44K; its normal report is 233K.

    See the evidence
    This period
    3.0M (the 28 Jun 2024 report)
    Normal report (median of 24 earlier)
    233K
    Typical spread (median absolute deviation)
    203K
    How far from its usual level
    +9.4
    Same report last year
    44K
    History used
    2,340 days
    2023-06-30: 44K2023-07-14: 43K2023-07-31: 34K2023-08-15: 43K2023-08-31: 30K2023-09-15: 30K2023-09-29: 30K2023-10-13: 21K2023-10-31: 38K2023-11-15: 36K2023-11-30: 217K2023-12-15: 203K2023-12-29: 248K2024-01-12: 384K2024-01-31: 428K2024-02-15: 607K2024-02-29: 634K2024-03-15: 615K2024-03-28: 921K2024-04-15: 1.0M2024-04-30: 914K2024-05-15: 929K2024-05-31: 840K2024-06-14: 904K2024-06-28: 3.0M
    the 28 Jun 2024 report24 earlier reportsnormal: 233K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  30. 12 Jun 2024Short interest and volume change

    had 840K shares sold short in the 31 May 2024 report, 33× the same report last year.

    Same report last year: 26K; its normal report is 124K.

    See the evidence
    This period
    840K (the 31 May 2024 report)
    Normal report (median of 24 earlier)
    124K
    Typical spread (median absolute deviation)
    96K
    How far from its usual level
    +5.0
    Same report last year
    26K
    History used
    2,312 days
    2023-05-31: 26K2023-06-15: 41K2023-06-30: 44K2023-07-14: 43K2023-07-31: 34K2023-08-15: 43K2023-08-31: 30K2023-09-15: 30K2023-09-29: 30K2023-10-13: 21K2023-10-31: 38K2023-11-15: 36K2023-11-30: 217K2023-12-15: 203K2023-12-29: 248K2024-01-12: 384K2024-01-31: 428K2024-02-15: 607K2024-02-29: 634K2024-03-15: 615K2024-03-28: 921K2024-04-15: 1.0M2024-04-30: 914K2024-05-15: 929K2024-05-31: 840K
    the 31 May 2024 report24 earlier reportsnormal: 124K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  31. 12 Jun 2024Insiders record

    Kahn Clare (director) bought 1,100 shares of SLDB ($8,437) (dated 11 Jun 2024)

  32. 11 Jun 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  33. 11 Jun 2024Filings record

    Director or officer change

  34. 25 May 2024Short interest and volume change

    had 929K shares sold short in the 15 May 2024 report, 23× the same report last year.

    Same report last year: 41K; its normal report is 43K.

    See the evidence
    This period
    929K (the 15 May 2024 report)
    Normal report (median of 24 earlier)
    43K
    Typical spread (median absolute deviation)
    20K
    How far from its usual level
    +17.7
    Same report last year
    41K
    History used
    2,296 days
    2023-05-15: 41K2023-05-31: 26K2023-06-15: 41K2023-06-30: 44K2023-07-14: 43K2023-07-31: 34K2023-08-15: 43K2023-08-31: 30K2023-09-15: 30K2023-09-29: 30K2023-10-13: 21K2023-10-31: 38K2023-11-15: 36K2023-11-30: 217K2023-12-15: 203K2023-12-29: 248K2024-01-12: 384K2024-01-31: 428K2024-02-15: 607K2024-02-29: 634K2024-03-15: 615K2024-03-28: 921K2024-04-15: 1.0M2024-04-30: 914K2024-05-15: 929K
    the 15 May 2024 report24 earlier reportsnormal: 43K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  35. 21 May 2024several at once

    saw 21 13F filers open a new position in the quarter ended 31 Mar 2024, 3.0× the same quarter last year, while it had 3.0M shares sold short in the 28 Jun 2024 report, 70× the same report last year. Two unrelated kinds of activity within 77 days.

    See the evidence (6 changes)

    Short interest and volume: Short interest spike became public on 25 Apr 2024

    Solid Biosciences had 1.0M shares sold short in the 15 Apr 2024 report, 23× the same report last year.

    This period
    1.0M (the 15 Apr 2024 report)
    Normal report (median of 24 earlier)
    43K
    Typical spread (median absolute deviation)
    13K
    How far from its usual level
    +20.1
    Same report last year
    45K
    History used
    2,266 days
    2023-04-14: 45K2023-04-28: 39K2023-05-15: 41K2023-05-31: 26K2023-06-15: 41K2023-06-30: 44K2023-07-14: 43K2023-07-31: 34K2023-08-15: 43K2023-08-31: 30K2023-09-15: 30K2023-09-29: 30K2023-10-13: 21K2023-10-31: 38K2023-11-15: 36K2023-11-30: 217K2023-12-15: 203K2023-12-29: 248K2024-01-12: 384K2024-01-31: 428K2024-02-15: 607K2024-02-29: 634K2024-03-15: 615K2024-03-28: 921K2024-04-15: 1.0M
    the 15 Apr 2024 report24 earlier reportsnormal: 43K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 10 May 2024

    Solid Biosciences had 914K shares sold short in the 30 Apr 2024 report, 24× the same report last year.

    This period
    914K (the 30 Apr 2024 report)
    Normal report (median of 24 earlier)
    43K
    Typical spread (median absolute deviation)
    15K
    How far from its usual level
    +17.4
    Same report last year
    39K
    History used
    2,281 days
    2023-04-28: 39K2023-05-15: 41K2023-05-31: 26K2023-06-15: 41K2023-06-30: 44K2023-07-14: 43K2023-07-31: 34K2023-08-15: 43K2023-08-31: 30K2023-09-15: 30K2023-09-29: 30K2023-10-13: 21K2023-10-31: 38K2023-11-15: 36K2023-11-30: 217K2023-12-15: 203K2023-12-29: 248K2024-01-12: 384K2024-01-31: 428K2024-02-15: 607K2024-02-29: 634K2024-03-15: 615K2024-03-28: 921K2024-04-15: 1.0M2024-04-30: 914K
    the 30 Apr 2024 report24 earlier reportsnormal: 43K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Institutional holdings: Many funds opening a new position became public on 15 May 2024

    Solid Biosciences saw 21 13F filers open a new position in the quarter ended 31 Mar 2024, 3.0× the same quarter last year.

    This period
    21 (the quarter ended 31 Mar 2024)
    Normal quarter (median of 8 earlier)
    6.5
    Typical spread (median absolute deviation)
    2
    How far from its usual level
    +4.8
    Same quarter last year
    7
    History used
    2,192 days
    2022-03-31: 82022-06-30: 162022-09-30: 62022-12-31: 82023-03-31: 72023-06-30: 22023-09-30: 32023-12-31: 42024-03-31: 21
    the quarter ended 31 Mar 20248 earlier quartersnormal: 6.5

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

    Short interest and volume: Short interest spike became public on 25 May 2024

    Solid Biosciences had 929K shares sold short in the 15 May 2024 report, 23× the same report last year.

    This period
    929K (the 15 May 2024 report)
    Normal report (median of 24 earlier)
    43K
    Typical spread (median absolute deviation)
    20K
    How far from its usual level
    +17.7
    Same report last year
    41K
    History used
    2,296 days
    2023-05-15: 41K2023-05-31: 26K2023-06-15: 41K2023-06-30: 44K2023-07-14: 43K2023-07-31: 34K2023-08-15: 43K2023-08-31: 30K2023-09-15: 30K2023-09-29: 30K2023-10-13: 21K2023-10-31: 38K2023-11-15: 36K2023-11-30: 217K2023-12-15: 203K2023-12-29: 248K2024-01-12: 384K2024-01-31: 428K2024-02-15: 607K2024-02-29: 634K2024-03-15: 615K2024-03-28: 921K2024-04-15: 1.0M2024-04-30: 914K2024-05-15: 929K
    the 15 May 2024 report24 earlier reportsnormal: 43K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 12 Jun 2024

    Solid Biosciences had 840K shares sold short in the 31 May 2024 report, 33× the same report last year.

    This period
    840K (the 31 May 2024 report)
    Normal report (median of 24 earlier)
    124K
    Typical spread (median absolute deviation)
    96K
    How far from its usual level
    +5.0
    Same report last year
    26K
    History used
    2,312 days
    2023-05-31: 26K2023-06-15: 41K2023-06-30: 44K2023-07-14: 43K2023-07-31: 34K2023-08-15: 43K2023-08-31: 30K2023-09-15: 30K2023-09-29: 30K2023-10-13: 21K2023-10-31: 38K2023-11-15: 36K2023-11-30: 217K2023-12-15: 203K2023-12-29: 248K2024-01-12: 384K2024-01-31: 428K2024-02-15: 607K2024-02-29: 634K2024-03-15: 615K2024-03-28: 921K2024-04-15: 1.0M2024-04-30: 914K2024-05-15: 929K2024-05-31: 840K
    the 31 May 2024 report24 earlier reportsnormal: 124K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 11 Jul 2024

    Solid Biosciences had 3.0M shares sold short in the 28 Jun 2024 report, 70× the same report last year.

    This period
    3.0M (the 28 Jun 2024 report)
    Normal report (median of 24 earlier)
    233K
    Typical spread (median absolute deviation)
    203K
    How far from its usual level
    +9.4
    Same report last year
    44K
    History used
    2,340 days
    2023-06-30: 44K2023-07-14: 43K2023-07-31: 34K2023-08-15: 43K2023-08-31: 30K2023-09-15: 30K2023-09-29: 30K2023-10-13: 21K2023-10-31: 38K2023-11-15: 36K2023-11-30: 217K2023-12-15: 203K2023-12-29: 248K2024-01-12: 384K2024-01-31: 428K2024-02-15: 607K2024-02-29: 634K2024-03-15: 615K2024-03-28: 921K2024-04-15: 1.0M2024-04-30: 914K2024-05-15: 929K2024-05-31: 840K2024-06-14: 904K2024-06-28: 3.0M
    the 28 Jun 2024 report24 earlier reportsnormal: 233K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

  36. 15 May 2024Institutional holdings change

    saw 21 13F filers open a new position in the quarter ended 31 Mar 2024, 3.0× the same quarter last year.

    Same quarter last year: 7; its normal quarter is 6.5.

    See the evidence
    This period
    21 (the quarter ended 31 Mar 2024)
    Normal quarter (median of 8 earlier)
    6.5
    Typical spread (median absolute deviation)
    2
    How far from its usual level
    +4.8
    Same quarter last year
    7
    History used
    2,192 days
    2022-03-31: 82022-06-30: 162022-09-30: 62022-12-31: 82023-03-31: 72023-06-30: 22023-09-30: 32023-12-31: 42024-03-31: 21
    the quarter ended 31 Mar 20248 earlier quartersnormal: 6.5

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  37. 10 May 2024Short interest and volume change

    had 914K shares sold short in the 30 Apr 2024 report, 24× the same report last year.

    Same report last year: 39K; its normal report is 43K.

    See the evidence
    This period
    914K (the 30 Apr 2024 report)
    Normal report (median of 24 earlier)
    43K
    Typical spread (median absolute deviation)
    15K
    How far from its usual level
    +17.4
    Same report last year
    39K
    History used
    2,281 days
    2023-04-28: 39K2023-05-15: 41K2023-05-31: 26K2023-06-15: 41K2023-06-30: 44K2023-07-14: 43K2023-07-31: 34K2023-08-15: 43K2023-08-31: 30K2023-09-15: 30K2023-09-29: 30K2023-10-13: 21K2023-10-31: 38K2023-11-15: 36K2023-11-30: 217K2023-12-15: 203K2023-12-29: 248K2024-01-12: 384K2024-01-31: 428K2024-02-15: 607K2024-02-29: 634K2024-03-15: 615K2024-03-28: 921K2024-04-15: 1.0M2024-04-30: 914K
    the 30 Apr 2024 report24 earlier reportsnormal: 43K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  38. 25 Apr 2024Short interest and volume change

    had 1.0M shares sold short in the 15 Apr 2024 report, 23× the same report last year.

    Same report last year: 45K; its normal report is 43K.

    See the evidence
    This period
    1.0M (the 15 Apr 2024 report)
    Normal report (median of 24 earlier)
    43K
    Typical spread (median absolute deviation)
    13K
    How far from its usual level
    +20.1
    Same report last year
    45K
    History used
    2,266 days
    2023-04-14: 45K2023-04-28: 39K2023-05-15: 41K2023-05-31: 26K2023-06-15: 41K2023-06-30: 44K2023-07-14: 43K2023-07-31: 34K2023-08-15: 43K2023-08-31: 30K2023-09-15: 30K2023-09-29: 30K2023-10-13: 21K2023-10-31: 38K2023-11-15: 36K2023-11-30: 217K2023-12-15: 203K2023-12-29: 248K2024-01-12: 384K2024-01-31: 428K2024-02-15: 607K2024-02-29: 634K2024-03-15: 615K2024-03-28: 921K2024-04-15: 1.0M
    the 15 Apr 2024 report24 earlier reportsnormal: 43K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  39. 10 Apr 2024Short interest and volume change

    had 921K shares sold short in the 28 Mar 2024 report, 25× the same report last year.

    Same report last year: 36K; its normal report is 42K.

    See the evidence
    This period
    921K (the 28 Mar 2024 report)
    Normal report (median of 24 earlier)
    42K
    Typical spread (median absolute deviation)
    12K
    How far from its usual level
    +17.6
    Same report last year
    36K
    History used
    2,248 days
    2023-03-31: 36K2023-04-14: 45K2023-04-28: 39K2023-05-15: 41K2023-05-31: 26K2023-06-15: 41K2023-06-30: 44K2023-07-14: 43K2023-07-31: 34K2023-08-15: 43K2023-08-31: 30K2023-09-15: 30K2023-09-29: 30K2023-10-13: 21K2023-10-31: 38K2023-11-15: 36K2023-11-30: 217K2023-12-15: 203K2023-12-29: 248K2024-01-12: 384K2024-01-31: 428K2024-02-15: 607K2024-02-29: 634K2024-03-15: 615K2024-03-28: 921K
    the 28 Mar 2024 report24 earlier reportsnormal: 42K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  40. 27 Mar 2024Short interest and volume change

    had 615K shares sold short in the 15 Mar 2024 report, 29× the same report last year.

    Same report last year: 21K; its normal report is 41K.

    See the evidence
    This period
    615K (the 15 Mar 2024 report)
    Normal report (median of 24 earlier)
    41K
    Typical spread (median absolute deviation)
    11K
    How far from its usual level
    +11.5
    Same report last year
    21K
    History used
    2,235 days
    2023-03-15: 21K2023-03-31: 36K2023-04-14: 45K2023-04-28: 39K2023-05-15: 41K2023-05-31: 26K2023-06-15: 41K2023-06-30: 44K2023-07-14: 43K2023-07-31: 34K2023-08-15: 43K2023-08-31: 30K2023-09-15: 30K2023-09-29: 30K2023-10-13: 21K2023-10-31: 38K2023-11-15: 36K2023-11-30: 217K2023-12-15: 203K2023-12-29: 248K2024-01-12: 384K2024-01-31: 428K2024-02-15: 607K2024-02-29: 634K2024-03-15: 615K
    the 15 Mar 2024 report24 earlier reportsnormal: 41K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

Showing the newest 40 of 92 entries; narrow the window or the kind of data to see older ones.

Not listed: 182 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001707502
Ticker
SLDB
Domain
solidbio.com
Employer name
Solid Biosciences, Inc. (1 unverified)
Hq location
MA|CHARLESTOWN|02129 (1 unverified)
Name
AavantiBio, Inc, Solid Biosciences Inc., Solid Biosciences Securities Corporation
  • DOL H-1B labor condition applications and PERM certifications83 data points4 May 2020 to 13 Jul 2026
  • SEC Form 13F institutional holdings315 data points31 Mar 2018 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)124 records29 Dec 2017 to 4 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)593 data points31 Dec 2015 to 30 Oct 2026
  • SEC Form 4 insider transactions101 records, 184 data points30 Jan 2018 to 20 Oct 2026
  • FINRA short interest (twice monthly)617 data points31 Jan 2018 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)4178 data points1 Aug 2018 to 20 Nov 2026